Mirati Therapeutics Inc. is a company in the U.S. stock market and it is a holding in 42 U.S.-traded ETFs. MRTX has around 3.1M shares in the U.S. ETF market. The largest ETF holder of MRTX is the SPDR S&P Biotech ETF (XBI), with approximately 721.87K shares. Investors may also find of interest that the ETF with the largest allocation to MRTX stock is iShares Genomics Immunology and Healthcare ETF (IDNA), with a portfolio weight of 3.95%. On average, U.S. ETFs allocate 0.48% of MRTX to their portfolios.

Additionally, MRTX is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MRTX as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 35.89%.